Page last updated: 2024-11-03

prochlorperazine and 2019 Novel Coronavirus Disease

prochlorperazine has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Otręba, M1
Kośmider, L1
Rzepecka-Stojko, A1
Kow, CS1
Hasan, SS1

Reviews

1 review available for prochlorperazine and 2019 Novel Coronavirus Disease

ArticleYear
Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
    European journal of pharmacology, 2020, Nov-15, Volume: 887

    Topics: Animals; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Chlorpromazine; Coronavirus Infect

2020

Other Studies

1 other study available for prochlorperazine and 2019 Novel Coronavirus Disease

ArticleYear
Prochlorperazine for nausea and vomiting accompanied COVID-19.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:2

    Topics: Antiemetics; COVID-19; Humans; Nausea; Prochlorperazine; Vomiting

2021